Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE28.4100
- TODAY'S CHANGE (%)-0.3500 (-1.2170%)
- Bid / Lots28.1500/ 10
- Ask / Lots29.0000/ 1
- Open / Previous Close28.6600 / 28.7600
- Day Range
- 52 Week Range
- Volume2,169,369
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 43368 | 28.66 |
| 09:34 ET | 3200 | 28.505 |
| 09:36 ET | 2611 | 28.4 |
| 09:38 ET | 10709 | 28.555 |
| 09:39 ET | 8566 | 28.505 |
| 09:41 ET | 4550 | 28.5 |
| 09:43 ET | 7180 | 28.53 |
| 09:45 ET | 2887 | 28.52 |
| 09:48 ET | 10357 | 28.59 |
| 09:50 ET | 11455 | 28.53 |
| 09:52 ET | 8006 | 28.515 |
| 09:54 ET | 5236 | 28.54 |
| 09:56 ET | 5401 | 28.585 |
| 09:57 ET | 5881 | 28.535 |
| 09:59 ET | 2000 | 28.515 |
| 10:01 ET | 13415 | 28.45 |
| 10:03 ET | 3732 | 28.505 |
| 10:06 ET | 10994 | 28.49 |
| 10:08 ET | 3000 | 28.44 |
| 10:10 ET | 4887 | 28.425 |
| 10:12 ET | 1373 | 28.415 |
| 10:14 ET | 4505 | 28.38 |
| 10:15 ET | 9449 | 28.4 |
| 10:17 ET | 3400 | 28.37 |
| 10:19 ET | 4829 | 28.32 |
| 10:21 ET | 5269 | 28.315 |
| 10:24 ET | 10543 | 28.26 |
| 10:26 ET | 4324 | 28.245 |
| 10:28 ET | 4100 | 28.27 |
| 10:30 ET | 3322 | 28.285 |
| 10:32 ET | 2200 | 28.26 |
| 10:33 ET | 4950 | 28.23 |
| 10:35 ET | 2700 | 28.215 |
| 10:37 ET | 6495 | 28.245 |
| 10:39 ET | 2447 | 28.24 |
| 10:42 ET | 6934 | 28.285 |
| 10:44 ET | 4613 | 28.27 |
| 10:46 ET | 1207 | 28.255 |
| 10:48 ET | 3764 | 28.24 |
| 10:50 ET | 2266 | 28.22 |
| 10:51 ET | 1500 | 28.21 |
| 10:53 ET | 2819 | 28.19 |
| 10:55 ET | 7199 | 28.205 |
| 10:57 ET | 4132 | 28.19 |
| 11:00 ET | 2236 | 28.185 |
| 11:02 ET | 6669 | 28.175 |
| 11:04 ET | 4656 | 28.16 |
| 11:06 ET | 4205 | 28.155 |
| 11:08 ET | 5665 | 28.19 |
| 11:09 ET | 4094 | 28.165 |
| 11:11 ET | 6510 | 28.195 |
| 11:13 ET | 6924 | 28.16 |
| 11:15 ET | 8093 | 28.18 |
| 11:18 ET | 9723 | 28.25 |
| 11:20 ET | 7362 | 28.29 |
| 11:22 ET | 2532 | 28.26 |
| 11:24 ET | 4973 | 28.255 |
| 11:26 ET | 2540 | 28.25 |
| 11:27 ET | 3231 | 28.28 |
| 11:29 ET | 2405 | 28.27 |
| 11:31 ET | 1652 | 28.28 |
| 11:33 ET | 3616 | 28.28 |
| 11:36 ET | 4082 | 28.31 |
| 11:38 ET | 4097 | 28.25 |
| 11:40 ET | 4303 | 28.26 |
| 11:42 ET | 1700 | 28.28 |
| 11:44 ET | 3839 | 28.26 |
| 11:45 ET | 2200 | 28.265 |
| 11:47 ET | 4869 | 28.25 |
| 11:49 ET | 3414 | 28.22 |
| 11:51 ET | 5786 | 28.23 |
| 11:54 ET | 5322 | 28.255 |
| 11:56 ET | 4003 | 28.26 |
| 11:58 ET | 5097 | 28.22 |
| 12:00 ET | 5209 | 28.23 |
| 12:02 ET | 3709 | 28.2301 |
| 12:03 ET | 11396 | 28.19 |
| 12:05 ET | 5509 | 28.18 |
| 12:07 ET | 5760 | 28.175 |
| 12:09 ET | 5227 | 28.195 |
| 12:12 ET | 4032 | 28.19 |
| 12:14 ET | 3825 | 28.165 |
| 12:16 ET | 1800 | 28.145 |
| 12:18 ET | 6845 | 28.17 |
| 12:20 ET | 6478 | 28.18 |
| 12:21 ET | 700 | 28.17 |
| 12:23 ET | 1600 | 28.18 |
| 12:25 ET | 6148 | 28.213 |
| 12:27 ET | 3700 | 28.211 |
| 12:30 ET | 1902 | 28.19 |
| 12:32 ET | 3690 | 28.195 |
| 12:34 ET | 2800 | 28.195 |
| 12:36 ET | 700 | 28.193 |
| 12:38 ET | 4076 | 28.195 |
| 12:39 ET | 4039 | 28.19 |
| 12:41 ET | 2103 | 28.203 |
| 12:43 ET | 4809 | 28.213 |
| 12:45 ET | 11343 | 28.24 |
| 12:48 ET | 1800 | 28.241 |
| 12:50 ET | 4513 | 28.233 |
| 12:52 ET | 3400 | 28.25 |
| 12:54 ET | 2989 | 28.265 |
| 12:56 ET | 3995 | 28.23 |
| 12:57 ET | 800 | 28.22 |
| 12:59 ET | 900 | 28.22 |
| 01:01 ET | 3557 | 28.2016 |
| 01:03 ET | 3943 | 28.213 |
| 01:06 ET | 4800 | 28.245 |
| 01:08 ET | 1312 | 28.24 |
| 01:10 ET | 600 | 28.24 |
| 01:12 ET | 5248 | 28.255 |
| 01:14 ET | 3400 | 28.265 |
| 01:15 ET | 4200 | 28.255 |
| 01:17 ET | 2958 | 28.28 |
| 01:19 ET | 2500 | 28.255 |
| 01:21 ET | 4103 | 28.235 |
| 01:24 ET | 3549 | 28.25 |
| 01:26 ET | 5046 | 28.24 |
| 01:28 ET | 4142 | 28.24 |
| 01:30 ET | 3300 | 28.259 |
| 01:32 ET | 6755 | 28.285 |
| 01:33 ET | 3415 | 28.25 |
| 01:35 ET | 2607 | 28.27 |
| 01:37 ET | 2220 | 28.29 |
| 01:39 ET | 5790 | 28.305 |
| 01:42 ET | 2600 | 28.31 |
| 01:44 ET | 5028 | 28.29 |
| 01:46 ET | 3328 | 28.28 |
| 01:48 ET | 7300 | 28.27 |
| 01:50 ET | 31056 | 28.23 |
| 01:51 ET | 6185 | 28.2 |
| 01:53 ET | 6051 | 28.175 |
| 01:55 ET | 2262 | 28.18 |
| 01:57 ET | 6364 | 28.235 |
| 02:00 ET | 3489 | 28.205 |
| 02:02 ET | 5820 | 28.235 |
| 02:04 ET | 4025 | 28.21 |
| 02:06 ET | 5098 | 28.23 |
| 02:08 ET | 16129 | 28.285 |
| 02:09 ET | 2840 | 28.25 |
| 02:11 ET | 2636 | 28.26 |
| 02:13 ET | 3815 | 28.28 |
| 02:15 ET | 1618 | 28.27 |
| 02:18 ET | 3565 | 28.26 |
| 02:20 ET | 2309 | 28.25 |
| 02:22 ET | 5509 | 28.275 |
| 02:24 ET | 5449 | 28.24 |
| 02:26 ET | 2132 | 28.25 |
| 02:27 ET | 800 | 28.245 |
| 02:29 ET | 1400 | 28.22 |
| 02:31 ET | 3400 | 28.21 |
| 02:33 ET | 6854 | 28.19 |
| 02:36 ET | 2286 | 28.19 |
| 02:38 ET | 1743 | 28.18 |
| 02:40 ET | 3788 | 28.17 |
| 02:42 ET | 4202 | 28.209 |
| 02:44 ET | 2938 | 28.205 |
| 02:45 ET | 3700 | 28.22 |
| 02:47 ET | 1700 | 28.23 |
| 02:49 ET | 5330 | 28.215 |
| 02:51 ET | 900 | 28.213 |
| 02:54 ET | 4216 | 28.23 |
| 02:56 ET | 18452 | 28.265 |
| 02:58 ET | 3781 | 28.25 |
| 03:00 ET | 5778 | 28.27 |
| 03:02 ET | 4533 | 28.23 |
| 03:03 ET | 3516 | 28.215 |
| 03:05 ET | 1773 | 28.19 |
| 03:07 ET | 4978 | 28.2 |
| 03:09 ET | 2924 | 28.205 |
| 03:12 ET | 7346 | 28.21 |
| 03:14 ET | 8105 | 28.2 |
| 03:16 ET | 3520 | 28.195 |
| 03:18 ET | 2681 | 28.2 |
| 03:20 ET | 5738 | 28.225 |
| 03:21 ET | 11523 | 28.23 |
| 03:23 ET | 4142 | 28.25 |
| 03:25 ET | 4555 | 28.265 |
| 03:27 ET | 4472 | 28.245 |
| 03:30 ET | 1196 | 28.24 |
| 03:32 ET | 2931 | 28.25 |
| 03:34 ET | 1331 | 28.245 |
| 03:36 ET | 8791 | 28.265 |
| 03:38 ET | 2712 | 28.275 |
| 03:39 ET | 6745 | 28.285 |
| 03:41 ET | 2788 | 28.295 |
| 03:43 ET | 4684 | 28.3 |
| 03:45 ET | 3784 | 28.325 |
| 03:48 ET | 21168 | 28.34 |
| 03:50 ET | 4979 | 28.375 |
| 03:52 ET | 11070 | 28.365 |
| 03:54 ET | 13387 | 28.4 |
| 03:56 ET | 29608 | 28.405 |
| 03:57 ET | 33413 | 28.405 |
| 03:59 ET | 57702 | 28.41 |
Apr 19, 2024
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024, from 8:15AM ET on Friday Apr 19, 2024 by Dow Jones
8:15AM ET on Friday Apr 19, 2024 by Dow Jones
Apr 17, 2024
Royalty Pharma Declares Second Quarter 2024 Dividend, from 8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:15AM ET on Wednesday Apr 17, 2024 by Dow JonesPress Release: Royalty Pharma Declares Second Quarter 2024 Dividend, from 8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 12, 2024
DJ Royalty Pharma Is Maintained at Buy by B of A Securities, from 8:11AM ET on Friday Apr 12, 2024 by Dow Jones
8:11AM ET on Friday Apr 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 17.0B | 11.2x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -21.7x | --- |
Catalent Inc | 10.2B | -7.9x | --- |
Jazz Pharmaceuticals PLC | 6.9B | 22.7x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Roivant Sciences Ltd | 9.2B | 2.2x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $17.0B |
|---|---|
Revenue (TTM) | $2.4B |
Shares Outstanding | 597.4M |
Dividend Yield | 2.96% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.47 |
EPS | $2.54 |
Book Value | $14.61 |
P/E Ratio | 11.2x |
Price/Sales (TTM) | 7.2 |
Price/Cash Flow (TTM) | 10.0x |
Operating Margin | 63.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
